p38-MAPK inhibitor Pexmetinib, Purity ≥98%

Cat. No.: X23-10-ZQ891

p38-MAPK inhibitor Pexmetinib, Purity ≥98%

Synonym: Pexmetinib; 945614-12-0; ARRY-614; Pexmetinib [INN]; Pexmetinib (ARRY-614); Pexmetinib(ARRY-614); p38-MAPK inhibitor

  • CAS Number: 945614-12-0
  • Compound CID: 24765037
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Pexmetinib, soluble in DMSO and ethanol and insoluble in water, targets the ATP-binding site of the kinase, thereby preventing phosphorylation of downstream substrates. It targets p38 MAPK and Tie-2.
Molecular Weight
556.63
Molecular Formula
C31H33FN6O3
Targets
p38 MAPK; Tie-2
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 96 mg/mL (172.46 mM); Water: Insoluble; Ethanol: 96 mg/mL (172.46 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Pexmetinib can be employed to explore the dual inhibition of MEK and AXL pathways in cancer treatment.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.